Is a complete SXTC research report available?

No complete published report is available for China SXT Pharmaceuticals, Inc. (SXTC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · USD

$0.07

+0.02 (+39.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SXTC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.4M
Revenue (ttm)	1.1M
Net income (ttm)	-6.2M
EPS (ttm)	-$9.13
Shares out	32.2M
Volume	540,704,493
Beta	1.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1M
Net income (ttm): -6.2M
EPS (ttm): -$9.13
Market cap: 2.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SXTC indicators

Market & fundamental data

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001723980
Company name	China SXT Pharmaceuticals, Inc.
Country	China
Country code	US
Cusip	G2161P165
Employees	56
Employees Change	-19%
Employees Change Percent	-25.33
Enterprise value	$-24.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	114.9
Industry PE Fwd	13.93
IPO Date	2019-01-04
Isin	VGG2161P1650
Last refreshed	2026-07-31
Market cap	$2.4M
Market cap category	Nano-Cap
Price	$0.07
Price currency	USD
Rev Per Employee	20,322.36x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	SXTC
Website	https://www.sxtchina.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-272.41%
FCF yield	-176.37%
P/B ratio	0x
P/S ratio	2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-625.89%
EBITDA Margin	-613.3%
Gross margin	21.85%
Gross Profit	$248,702
Gross Profit Growth	-32.31%
Gross Profit Growth Q	-44.67%
Gross Profit Growth3 Y	-16.44%
Gross Profit Growth5 Y	-38.56%
Net Income	$-6.2M
Net Income Growth Years	0%
Pretax Margin	-545.24%
Profit Per Employee	$-110,805
ROA	-15.78
Roa5y	-9.63
ROCE	-23.43
ROE	-27.49
Roe5y	-29.04
ROIC	-284.1
Roic5y	-465.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-99.97%
Cagr3y	-97.67%
Cagr5y	-96.03%
EPS Growth Years	4
Revenue Growth	-34.63x
Revenue Growth Q	-43.88x
Revenue Growth Years	0x
Revenue Growth3 Y	-16.74x
Revenue Growth5 Y	-24.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$34.8M
Cash	$28.3M
Current Assets	$34.5M
Current Liabilities	$4.3M
Debt	$1.1M
Debt Equity	$0.04
Equity	$29.7M
Interest Coverage	-113.1
Liabilities	$5M
Long Term Assets	$244,852
Long Term Liabilities	$697,832
Net Cash	$27.2M
Net Cash By Market Cap	$1,194
Net Cash Growth	224.76%
Net Debt Equity	$-0.92
Tangible Book Value	$29.7M
Tangible Book Value Per Share	$31
WACC	11.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.93
Inventory Turnover	0.44
Net Working Capital	$2.3M
Quick ratio	7.23
Working Capital	$30.2M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-99.97%
200-day SMA	68.4
3Y total return	-100%
50-day SMA	1.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	56,035,517.2
All Time High Change	-100%
All Time High Date	2019-01-10
All Time Low	0.05
All Time Low Change	57.54%
All Time Low Date	2026-07-29
ATR	0.32
Beta	1.82
Beta1y	2.35
Beta2y	1.03
Ch YTD	-99.97
High	0.09
High52	1,047
High52 Date	2026-01-08
High52ch	-99.99%
Low	0.06
Low52	0.05
Low52 Date	2026-07-29
Low52ch	57.54%
Ma50ch	-96.11%
Premarket Change Percent	34.29
Premarket Price	$0.07
Premarket Volume	308,818,628
Price vs 200-day SMA	-99.89%
RSI	21.19
RSI Monthly	16.91
RSI Weekly	26.37
Sharpe ratio	-1.87x
Sortino ratio	-2.1
Tr YTD	-99.97
Tr1m	-96.4%
Tr1w	-78.02%
Tr3m	-96.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.1M
Operating margin	-625.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,944,758%
Float Percent	99.15%
Net Borrowing	144,159
Shares Insiders	0.85%
Shares Institutions	0.24%
Shares Out	32,218,081
Shares Qo Q	-24.27%
Short Ratio	0.5
Short Shares	0.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.3M
Adjusted OCF	-9,323,195
Average Volume	70,171,718.35x
Bv Per Share	31.01
Ch1m	-96.4
Ch1w	-78.02
Ch1y	-99.97
Ch3m	-96.43
Ch3y	-100
Ch5y	-100
Ch6m	-99.03
Change	39.24%
Change From Open	4.43
Close	0.05
Days Gap	33.33
Depreciation Amortization	73,668
Dollar Volume	39,525,498.4
Earnings Date	2019-08-19
Earnings Time	bmo
EBIT	$-7.1M
EBITDA	$-7M
EPS	$-9.13
F Score	3
FCF	$-4M
FCF EV Yield	16.12x
FCF Per Share	$-0.12
Financing CF	14,433,521
Fiscal Year End	March
Founded	2,005
Investing CF	-1,250,921
Ipr	-98.23
Iprfo	-100
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2019-08-19
Last Report Date	2026-03-31
Last Split Date	2026-02-03
Last Split Type	Reverse
Last10k Filing Date	2026-07-01
Ma150	20.56
Ma150ch	-99.64%
Ma20	1.76
Ma20ch	-95.85%
Net CF	10,046,801
Open	0.07
Optionable	No
Position In Range	32.25
Post Close	0.07
Postmarket Change Percent	-13.82
Postmarket Price	$0.06
Ppne	238,524
Pre Close	0.05
Price Date	2026-07-30
Ptbv Ratio	0.08
Relative Volume	7.71x
Revenue	1,138,052x
SBC By Revenue	466.21x
Share Based Comp	5,305,739
Tr6m	-99.03%
Views	1,056
Volume	540,704,493
Z Score	12.3

China SXT Pharmaceuticals, Inc. (SXTC)

Coverage state: Market snapshot only — no published research

Generate the first SXTC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SXTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SXTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SXTC

Frequently asked questions